MyFinsight
Home
Blog
About
Contact
Back
Income Statement
Mirum Pharmaceuticals, Inc. (MIRM)
Mirum Pharmaceuticals, Inc. (MIRM)
source: myfinsight.com
Download
Download image
Net loss
-$790,155K
(-5283.63%↓ Y/Y)
Net loss before
provision for income taxes
-$789,680K
(-5686.05%↓ Y/Y)
Provision for income taxes
$475K
(-53.84%↓ Y/Y)
Interest income
$3,401K
(12.50%↑ Y/Y)
Livmarli
$113,804K
(55.42%↑ Y/Y)
Bile Acid Medicines
$46,078K
(20.12%↑ Y/Y)
Loss from operations
-$789,465K
(-5099.66%↓ Y/Y)
Interest expense
$3,616K
(0.56%↑ Y/Y)
Product sales, net
$159,882K
(43.28%↑ Y/Y)
Total operating
expenses
$949,347K
(648.89%↑ Y/Y)
Acquired in-process
research and development
$726,302K
Research and development
$97,910K
(112.64%↑ Y/Y)
Selling, general and
administrative
$96,330K
(66.93%↑ Y/Y)
Cost of sales
$28,805K
(25.14%↑ Y/Y)
Back